Ceryvyn Therapeutics Limited (ASX:CYV)

Australia · Delayed Price · Currency is AUD

0.0100

0.00 (0.00%)

Sep 18, 2026, 4:10 PM AEST

Ceryvyn Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 17, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Market Capitalization	14	21	739	382	257	387
Market Cap Growth	-98.15%	-97.22%	93.39%	48.68%	-33.67%	-17.33%
Enterprise Value	-16	-13	886	417	178	266
Last Close Price	0.01	0.01	0.60	0.35	0.48	0.96

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 17, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
PE Ratio	0.04	0.06	-	-	-	-
Forward PE	-	109.83	109.83	109.83	109.83	109.83
PS Ratio	13679.78	20519.67	3240.23	972.82	443.86	1341.13
PB Ratio	0.46	0.69	-2.41	-3.36	-29.22	5.56
P/TBV Ratio	0.46	0.69	-	-	-	5.56

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 17, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
EV/Sales Ratio	-	-	3884.01	1061.86	307.67	921.14

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 17, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Debt / Equity Ratio	-	-	-1.23	-2.65	-14.67	-
Net Debt / Equity Ratio	-1.01	-1.01	-0.99	-0.37	0.57	-0.93
Net Debt / EBITDA Ratio	2.52	2.52	-1.25	-0.15	0.02	0.46
Net Debt / FCF Ratio	2.40	2.40	-1.24	-0.17	0.03	0.63
Asset Turnover	0	0	0.00	0.00	0.01	0.00
Quick Ratio	13.43	13.43	0.22	2.88	5.11	4.25
Current Ratio	13.78	13.78	0.22	2.94	5.25	4.97
Return on Equity (ROE)	-	-	-	-	-676.67%	-101.29%
Return on Assets (ROA)	-12.59%	-12.59%	-80.66%	-83.43%	-118.18%	-60.81%
Return on Capital Employed (ROCE)	-40.30%	-40.30%	78.80%	-153.80%	-187.80%	-201.10%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 17, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Earnings Yield	2415.57%	1610.38%	-33.99%	-86.41%	-83.34%	-34.78%
FCF Yield	-91.36%	-60.91%	-33.13%	-63.19%	-70.54%	-26.73%
Buyback Yield / Dilution	-10.23%	-10.23%	-91.90%	-44.18%	-25.91%	-9.71%